Jamie Clark
Stock Analyst at Rothschild & Co Redburn
(2.83)
# 2,792
Out of 5,005 analysts
15
Total ratings
80%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Initiated Coverage: Buy | $203 | $177.33 | +14.48% | 1 | Sep 8, 2026 | |
| NTRA Natera | Initiated Coverage: Buy | $385 | $411.77 | -6.50% | 1 | Sep 8, 2026 | |
| TEM Tempus AI | Initiated Coverage: Hold | $67 | $85.08 | -21.25% | 1 | Sep 8, 2026 | |
| ICLR ICON Public Limited Company | Downgraded: Hold | $236 → $100 | $175.57 | -43.04% | 3 | Feb 17, 2026 | |
| CERT Certara | Initiated Coverage: Buy | $10 | $9.13 | +9.53% | 1 | Nov 21, 2025 | |
| WST West Pharmaceutical Services | Initiated Coverage: Buy | $311 | $375.65 | n/a | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgraded: Hold | $474 | $615.90 | n/a | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgraded: Buy | $188 → $182 | $294.59 | n/a | 3 | May 23, 2025 | |
| DGX Quest Diagnostics | Initiated Coverage: Buy | $195 | $237.62 | n/a | 1 | Apr 2, 2025 | |
| LH Labcorp Holdings | Initiated Coverage: Buy | $276 | $309.57 | n/a | 1 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | CHF 650.00 | CHF 584.20 | n/a | 1 | Nov 27, 2024 |
Guardant Health
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $203
Current: $177.33
Upside: +14.48%
Natera
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $385
Current: $411.77
Upside: -6.50%
Tempus AI
Sep 8, 2026
Initiated Coverage: Hold
Price Target: $67
Current: $85.08
Upside: -21.25%
ICON Public Limited Company
Feb 17, 2026
Downgraded: Hold
Price Target: $236 → $100
Current: $175.57
Upside: -43.04%
Certara
Nov 21, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $9.13
Upside: +9.53%
West Pharmaceutical Services
Sep 15, 2025
Initiated Coverage: Buy
Price Target: $311
Current: $375.65
Upside: n/a
Medpace Holdings
Sep 3, 2025
Downgraded: Hold
Price Target: $474
Current: $615.90
Upside: n/a
Charles River Laboratories International
May 23, 2025
Upgraded: Buy
Price Target: $188 → $182
Current: $294.59
Upside: n/a
Quest Diagnostics
Apr 2, 2025
Initiated Coverage: Buy
Price Target: $195
Current: $237.62
Upside: n/a
Labcorp Holdings
Apr 2, 2025
Initiated Coverage: Buy
Price Target: $276
Current: $309.57
Upside: n/a
Nov 27, 2024
Initiated Coverage: Buy
Price Target: CHF 650.00
Current: CHF 584.20
Upside: n/a